Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associated with euglycemic diabetic ketoacidosis (DKA) in some rare cases. We report the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Calçada, Marta Brandão, Fernandes, Luís, Soares Costa, Rita, Montezinho, Sara, Martins Duarte, Filipa, Frutuoso, Luísa, Freitas, Ana Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167627/
https://www.ncbi.nlm.nih.gov/pubmed/33917274
http://dx.doi.org/10.3390/clinpract11020031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167627/
https://www.ncbi.nlm.nih.gov/pubmed/33917274
http://dx.doi.org/10.3390/clinpract11020031

Ejemplares similares